Clinical trial
Did you know that Imbifemu effectiveness has been confirmed in a clinical trial?
A clinical study proving the efficacy of Imbifem was conducted on 25 patients aged 25-35 years, who are between 7 and 11 weeks of pregnancy, suffering from hyperemesis pregnant. It is worth noting that all patients had normal eating habits, not to smoke and to apply the test product at a dose of 25 drops 3 times a day for 7 days.
After one week, the clinical condition of patients was evaluated and compared with the state of patients, who are in the control group, receiving only placebo. As many as 70% of pregnant women (treated group) decreased symptoms of morning sickness in 7 days, and in 21% of cases, these symptoms disappeared as early as day 2 receiving treatment.
The effectiveness confirmed in clinical studies.
